A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
Lumicell, Inc.
BicycleTx Limited
Bolt Biotherapeutics, Inc.
Marengo Therapeutics, Inc.
Revolution Medicines, Inc.
University of Maryland, Baltimore
Mirror Biologics, Inc.
Radboud University Medical Center